UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.ES8-1-ES8-1

Faratian, D

2010

Volltextzugriff (PDF)

Bronchial basal cell and epithelial repair

Thorax, 2004-08, Vol.59 (8), p.693-693

Faratian, D

2004

Volltextzugriff (PDF)

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

International journal of gynecological cancer, 2006-04, Vol.16 (3), p.972-978

2006

Volltextzugriff (PDF)

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.60-60

2008

Volltextzugriff (PDF)

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

European heart journal, 2013-08, Vol.34 (suppl 1), p.P5689-P5689

2013

Volltextzugriff (PDF)

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-07-02

2010

Volltextzugriff (PDF)

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-02-08

2010

Volltextzugriff (PDF)

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-12

2010

Volltextzugriff (PDF)

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Annals of oncology, 2012-09, Vol.23, p.ix96

2012

Volltextzugriff (PDF)

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-05-06

2010

Volltextzugriff (PDF)

miRNA Profiling of Endocrine-Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5130-5130

2009

Volltextzugriff (PDF)

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5132-5132

2009

Volltextzugriff (PDF)

Genes Regulated by miRNA in Endocrine-Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5149-5149

2009

Volltextzugriff (PDF)

Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5055-5055

2011

Volltextzugriff (PDF)

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

European journal of cancer supplements, 2007, Vol.5 (3), p.30-30

2007

Volltextzugriff (PDF)

Rapid screening of tissue microarrays for Her-2 FISH testing is a safe, accurate, efficient and economic method enabling provision of an entirely FISH-based Her-2 testing service

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2070

2009

Volltextzugriff (PDF)

Effects of letrozole and anastrozole on low ER expressing invasive breast carcinomas: results from a randomised trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.1065

2009

Volltextzugriff (PDF)

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

Breast cancer research : BCR, 2008-01, Vol.10 (S2), p.P77-P77, Article P77

2008

Volltextzugriff (PDF)

Randomized pre-operative study of 750 mg of fulvestrant and 20 mg tamoxifen in premenopausal women with estrogen receptor-positive breast cancer

European journal of cancer supplements, 2006-03, Vol.4 (2), p.150-151

2006

Volltextzugriff (PDF)

Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

European journal of cancer supplements, 2006-03, Vol.4 (2), p.81-82

2006

Volltextzugriff (PDF)

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Journal of Obstetrics and Gynaecology, 2006, Vol.26 (4), p.385-387

2006

Volltextzugriff (PDF)

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Journal of visualized experiments, 2013-01 (71)

2013

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaHumans

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(2)
Biopsy
(1)
Cancer
(1)
Chemotherapy
(1)
Endometrial Cancer
(1)
Hysterectomy
(1)
Lung Alert
(1)
Medical Prognosis
(1)
Poster Presentation
(1)
Radiation Therapy
(1)
Uterine Cancer
(1)

6 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Bronchial basal cell and epithelial repair

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

miRNA Profiling of Endocrine-Resistant Breast Tumours

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Genes Regulated by miRNA in Endocrine-Resistant Breast Tumours

Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC)

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

Rapid screening of tissue microarrays for Her-2 FISH testing is a safe, accurate, efficient and economic method enabling provision of an entirely FISH-based Her-2 testing service

Effects of letrozole and anastrozole on low ER expressing invasive breast carcinomas: results from a randomised trial

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

Randomized pre-operative study of 750 mg of fulvestrant and 20 mg tamoxifen in premenopausal women with estrogen receptor-positive breast cancer

Effects of letrozole and anastrozole on ductal carcinoma in situ (DCIS): results from a randomised trial

Ovarian choriocarcinoma masquerading as ectopic pregnancy

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Aktive Filter

Suchergebnisse filtern